Xiteng Yin

518 total citations
16 papers, 374 citations indexed

About

Xiteng Yin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiteng Yin has authored 16 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Xiteng Yin's work include Cancer, Hypoxia, and Metabolism (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Fibroblast Growth Factor Research (3 papers). Xiteng Yin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Fibroblast Growth Factor Research (3 papers). Xiteng Yin collaborates with scholars based in China and Hong Kong. Xiteng Yin's co-authors include Wei Han, Wei Zheng, Yu Cai, Chuanhui Song, Yufeng Wang, Chuanchao Tang, Wenguang Xu, Shengwei Han, Xiaochen Dong and Pingping Liang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Xiteng Yin

14 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiteng Yin China 10 168 157 81 79 77 16 374
Zhong Du China 11 126 0.8× 194 1.2× 51 0.6× 81 1.0× 42 0.5× 24 374
Jiahui Yong China 12 162 1.0× 177 1.1× 90 1.1× 94 1.2× 88 1.1× 22 467
Xiangyu Su China 10 98 0.6× 111 0.7× 62 0.8× 56 0.7× 53 0.7× 33 361
Huanrong Ma China 8 153 0.9× 130 0.8× 65 0.8× 87 1.1× 118 1.5× 12 390
Shiqiang Zhang China 13 128 0.8× 112 0.7× 71 0.9× 54 0.7× 50 0.6× 30 404
Hua‐yang Fan China 10 208 1.2× 132 0.8× 94 1.2× 106 1.3× 87 1.1× 19 474
Zhaoze Guo China 12 223 1.3× 136 0.9× 148 1.8× 54 0.7× 127 1.6× 28 497
Shengxin Huang China 11 115 0.7× 165 1.1× 92 1.1× 66 0.8× 49 0.6× 17 439
Jingkang He China 12 176 1.0× 190 1.2× 40 0.5× 72 0.9× 65 0.8× 19 457

Countries citing papers authored by Xiteng Yin

Since Specialization
Citations

This map shows the geographic impact of Xiteng Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiteng Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiteng Yin more than expected).

Fields of papers citing papers by Xiteng Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiteng Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiteng Yin. The network helps show where Xiteng Yin may publish in the future.

Co-authorship network of co-authors of Xiteng Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiteng Yin. A scholar is included among the top collaborators of Xiteng Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiteng Yin. Xiteng Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Yin, Xiteng, et al.. (2024). Integrated analyses reveal prognostic markers associated with cancer-associated fibroblasts in oral squamous cell carcinoma. SHILAP Revista de lepidopterología. 27(1). 111–126.
3.
Yin, Xiteng, Wei Zheng, Yufeng Wang, et al.. (2023). Large-Scale Identification of Lysine Crotonylation Reveals Its Potential Role in Oral Squamous Cell Carcinoma. Cancer Management and Research. Volume 15. 1165–1179. 5 indexed citations
4.
Yin, Xiteng, et al.. (2023). Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma. BioMed Research International. 2023(1). 4444869–4444869. 8 indexed citations
5.
Zhang, Hongbo, Xiteng Yin, Xinyu Zhang, et al.. (2022). HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma. Technology in Cancer Research & Treatment. 21. 2213860090–2213860090. 21 indexed citations
6.
Zheng, Wei, Huihui Zou, Gongyuan Liu, et al.. (2021). Peroxidase-mimicking evodiamine/indocyanine green nanoliposomes for multimodal imaging-guided theranostics for oral squamous cell carcinoma. Bioactive Materials. 6(7). 2144–2157. 44 indexed citations
7.
8.
Han, Shengwei, et al.. (2020). The Management of Head and Neck Sarcoma. Journal of Craniofacial Surgery. 31(2). e189–e192. 10 indexed citations
9.
Han, Shengwei, Xiteng Yin, Yufeng Wang, Wenguang Xu, & Wei Cheng. (2020). Co-expression of HIF-1 and TLR3 is associated with poor prognosis in oral squamous cell carcinoma.. PubMed. 13(1). 65–72. 3 indexed citations
10.
Yin, Xiteng, Shengwei Han, Chuanhui Song, et al.. (2019). Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells. Cellular Oncology. 42(4). 459–475. 44 indexed citations
11.
Yin, Xiteng, Weidong Yang, Wei Zheng, et al.. (2019). HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis. BioMed Research International. 2019. 1–13. 17 indexed citations
12.
Zheng, Wei, Pingping Liang, Chuanhui Song, et al.. (2019). Carrier-free nano-integrated strategy for synergetic cancer anti-angiogenic therapy and phototherapy. Chemical Science. 10(9). 2778–2784. 94 indexed citations
13.
Xu, Wenguang, Huihui Zou, Wei Zheng, et al.. (2019). Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma. Aging. 11(11). 3601–3623. 8 indexed citations
14.
Yin, Xiteng, Wei Zheng, Chuanhui Song, et al.. (2018). Metformin sensitizes hypoxia-induced gefitinib treatment resistance of HNSCC via cell cycle regulation and EMT reversal. Cancer Management and Research. Volume 10. 5785–5798. 16 indexed citations
15.
Zheng, Wei, Xiteng Yin, Yu Cai, et al.. (2018). Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma. International Journal of Nanomedicine. Volume 13. 1505–1524. 61 indexed citations
16.
Xu, Wenguang, Yufeng Wang, Wei Zheng, et al.. (2017). Prognostic factors of palatal mucoepidermoid carcinoma: a retrospective analysis based on a double-center study. Scientific Reports. 7(1). 43907–43907. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhong Du Breakdown of academic impact, for papers by Jiahui Yong Breakdown of academic impact, for papers by Xiangyu Su Breakdown of academic impact, for papers by Huanrong Ma Breakdown of academic impact, for papers by Shiqiang Zhang Breakdown of academic impact, for papers by Hua‐yang Fan Breakdown of academic impact, for papers by Zhaoze Guo Breakdown of academic impact, for papers by Shengxin Huang Breakdown of academic impact, for papers by Jingkang He
Rankless by CCL
2026